John Carroll
Concepts (520)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotid Body | 26 | 2015 | 43 | 6.890 |
Why?
| | Oocytes | 18 | 2025 | 95 | 6.340 |
Why?
| | Meiosis | 11 | 2025 | 62 | 2.820 |
Why?
| | Chemoreceptor Cells | 14 | 2023 | 23 | 2.740 |
Why?
| | Mitochondria | 12 | 2025 | 446 | 2.310 |
Why?
| | Potassium Channels, Tandem Pore Domain | 7 | 2015 | 11 | 2.010 |
Why?
| | Calcium | 10 | 2025 | 373 | 1.880 |
Why?
| | Fertility | 3 | 2025 | 32 | 1.800 |
Why?
| | Hyperoxia | 8 | 2023 | 26 | 1.760 |
Why?
| | Respiration, Artificial | 10 | 2024 | 293 | 1.470 |
Why?
| | Aortic Valve Stenosis | 9 | 2026 | 79 | 1.420 |
Why?
| | Oxygen | 11 | 2024 | 338 | 1.350 |
Why?
| | Animals | 52 | 2025 | 13526 | 1.300 |
Why?
| | Embryonic Development | 4 | 2025 | 18 | 1.240 |
Why?
| | Blastocyst | 3 | 2025 | 15 | 1.150 |
Why?
| | Cell Nucleus | 2 | 2025 | 187 | 1.020 |
Why?
| | Microtubules | 3 | 2025 | 35 | 0.970 |
Why?
| | Rats | 19 | 2015 | 3162 | 0.920 |
Why?
| | Membrane Potentials | 9 | 2024 | 100 | 0.910 |
Why?
| | Cell Hypoxia | 5 | 2013 | 82 | 0.870 |
Why?
| | Respiration Disorders | 3 | 2023 | 22 | 0.850 |
Why?
| | Animals, Newborn | 15 | 2015 | 357 | 0.840 |
Why?
| | Foramen Ovale, Patent | 5 | 2025 | 32 | 0.840 |
Why?
| | Lysosomes | 1 | 2024 | 68 | 0.840 |
Why?
| | Mice | 23 | 2025 | 5982 | 0.820 |
Why?
| | Mitral Valve | 3 | 2026 | 57 | 0.810 |
Why?
| | Mitral Valve Insufficiency | 2 | 2026 | 56 | 0.790 |
Why?
| | Female | 57 | 2026 | 28782 | 0.770 |
Why?
| | Actins | 1 | 2023 | 114 | 0.750 |
Why?
| | Stroke | 8 | 2025 | 520 | 0.750 |
Why?
| | Humans | 77 | 2026 | 53230 | 0.720 |
Why?
| | Lung Diseases | 3 | 2019 | 84 | 0.700 |
Why?
| | Infant, Extremely Premature | 4 | 2024 | 33 | 0.670 |
Why?
| | Mitochondrial Diseases | 1 | 2021 | 45 | 0.660 |
Why?
| | Nerve Tissue Proteins | 7 | 2015 | 193 | 0.650 |
Why?
| | Hydrogen Peroxide | 1 | 2021 | 121 | 0.650 |
Why?
| | Mitral Valve Annuloplasty | 1 | 2019 | 6 | 0.590 |
Why?
| | Kinetochores | 2 | 2022 | 4 | 0.590 |
Why?
| | Patch-Clamp Techniques | 7 | 2015 | 105 | 0.580 |
Why?
| | Shock, Cardiogenic | 1 | 2019 | 35 | 0.580 |
Why?
| | Registries | 11 | 2026 | 652 | 0.580 |
Why?
| | Journal Impact Factor | 1 | 2018 | 9 | 0.570 |
Why?
| | Cystic Fibrosis | 3 | 2015 | 155 | 0.550 |
Why?
| | DNA, Mitochondrial | 4 | 2024 | 116 | 0.550 |
Why?
| | Publishing | 1 | 2018 | 41 | 0.550 |
Why?
| | Rats, Sprague-Dawley | 10 | 2015 | 1544 | 0.540 |
Why?
| | Sleep Apnea Syndromes | 4 | 2023 | 34 | 0.540 |
Why?
| | Cyclin A2 | 1 | 2017 | 2 | 0.540 |
Why?
| | Chromosomes, Mammalian | 1 | 2017 | 4 | 0.540 |
Why?
| | Home Care Services | 4 | 2023 | 72 | 0.540 |
Why?
| | Periodicals as Topic | 1 | 2018 | 63 | 0.530 |
Why?
| | Orthopedics | 1 | 2018 | 54 | 0.530 |
Why?
| | Sleep Apnea, Obstructive | 5 | 2018 | 70 | 0.520 |
Why?
| | Male | 42 | 2026 | 27435 | 0.520 |
Why?
| | Adenosine Triphosphate | 3 | 2013 | 211 | 0.510 |
Why?
| | Infant, Premature | 7 | 2023 | 331 | 0.510 |
Why?
| | Tracheostomy | 2 | 2023 | 76 | 0.490 |
Why?
| | M Phase Cell Cycle Checkpoints | 1 | 2015 | 5 | 0.470 |
Why?
| | Maternal Age | 1 | 2015 | 42 | 0.470 |
Why?
| | Health Personnel | 2 | 2015 | 259 | 0.460 |
Why?
| | Hydrogen Sulfide | 1 | 2015 | 8 | 0.450 |
Why?
| | DNA Damage | 2 | 2023 | 309 | 0.450 |
Why?
| | Transient Receptor Potential Channels | 1 | 2015 | 5 | 0.450 |
Why?
| | Fertilization | 2 | 2025 | 7 | 0.450 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 83 | 0.440 |
Why?
| | Enzyme Inhibitors | 2 | 2014 | 371 | 0.440 |
Why?
| | Transition to Adult Care | 1 | 2015 | 24 | 0.440 |
Why?
| | Pregnancy | 8 | 2025 | 2608 | 0.440 |
Why?
| | Respiratory Therapy | 1 | 2015 | 36 | 0.440 |
Why?
| | Mitosis | 2 | 2025 | 86 | 0.430 |
Why?
| | Chromosome Segregation | 2 | 2025 | 11 | 0.430 |
Why?
| | Oogenesis | 3 | 2025 | 19 | 0.420 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2014 | 33 | 0.420 |
Why?
| | Electron Transport Complex IV | 1 | 2013 | 24 | 0.410 |
Why?
| | Septal Occluder Device | 4 | 2025 | 36 | 0.400 |
Why?
| | Child | 20 | 2020 | 7379 | 0.400 |
Why?
| | Pediatrics | 2 | 2016 | 307 | 0.400 |
Why?
| | Piperidines | 3 | 2021 | 98 | 0.400 |
Why?
| | Staphylococcal Infections | 1 | 2015 | 271 | 0.390 |
Why?
| | Sleep | 5 | 2021 | 195 | 0.380 |
Why?
| | Clinical Competence | 1 | 2015 | 406 | 0.380 |
Why?
| | Time Factors | 9 | 2024 | 2991 | 0.370 |
Why?
| | Neural Conduction | 3 | 2009 | 34 | 0.370 |
Why?
| | Analysis of Variance | 6 | 2015 | 547 | 0.360 |
Why?
| | Bronchopulmonary Dysplasia | 3 | 2023 | 64 | 0.360 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2015 | 523 | 0.350 |
Why?
| | Treatment Outcome | 15 | 2026 | 5595 | 0.350 |
Why?
| | Potassium Channels, Inwardly Rectifying | 1 | 2011 | 7 | 0.350 |
Why?
| | Aortic Valve | 7 | 2024 | 130 | 0.340 |
Why?
| | Infant, Newborn | 14 | 2024 | 2913 | 0.340 |
Why?
| | Infant | 16 | 2024 | 3805 | 0.340 |
Why?
| | Osteogenesis Imperfecta | 2 | 2022 | 37 | 0.340 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channels | 1 | 2011 | 12 | 0.340 |
Why?
| | United States | 15 | 2026 | 5409 | 0.340 |
Why?
| | Collagen Type I | 2 | 2022 | 83 | 0.340 |
Why?
| | Pulmonary Ventilation | 1 | 2010 | 12 | 0.330 |
Why?
| | Mechanotransduction, Cellular | 1 | 2011 | 42 | 0.330 |
Why?
| | Mice, Knockout | 3 | 2025 | 910 | 0.330 |
Why?
| | Cardiac Catheterization | 3 | 2025 | 229 | 0.320 |
Why?
| | Aging | 3 | 2004 | 714 | 0.320 |
Why?
| | Risk Factors | 14 | 2024 | 4017 | 0.320 |
Why?
| | Signal Transduction | 3 | 2025 | 1748 | 0.320 |
Why?
| | Prometaphase | 1 | 2009 | 1 | 0.320 |
Why?
| | Meiotic Prophase I | 1 | 2009 | 1 | 0.320 |
Why?
| | Dynamins | 3 | 2025 | 8 | 0.300 |
Why?
| | Zygote | 2 | 2025 | 10 | 0.290 |
Why?
| | Respiration | 6 | 2024 | 94 | 0.280 |
Why?
| | Aged | 12 | 2026 | 10429 | 0.280 |
Why?
| | Infant, Premature, Diseases | 3 | 2024 | 97 | 0.270 |
Why?
| | Receptors, Dopamine D2 | 2 | 2005 | 17 | 0.270 |
Why?
| | Apnea | 2 | 2024 | 16 | 0.260 |
Why?
| | Bradycardia | 2 | 2024 | 38 | 0.260 |
Why?
| | Age Factors | 6 | 2024 | 1136 | 0.260 |
Why?
| | Neurotransmitter Agents | 2 | 2009 | 32 | 0.250 |
Why?
| | Chronic Disease | 5 | 2019 | 580 | 0.250 |
Why?
| | Medicare | 3 | 2023 | 280 | 0.250 |
Why?
| | Aged, 80 and over | 8 | 2026 | 3494 | 0.250 |
Why?
| | Cyclin B1 | 2 | 2020 | 7 | 0.250 |
Why?
| | Sleep Stages | 3 | 2011 | 42 | 0.240 |
Why?
| | Delivery of Health Care | 2 | 2019 | 317 | 0.240 |
Why?
| | Risk Assessment | 5 | 2021 | 1368 | 0.240 |
Why?
| | Polysomnography | 8 | 2015 | 76 | 0.230 |
Why?
| | Parthenogenesis | 1 | 2025 | 3 | 0.230 |
Why?
| | Metalloproteases | 1 | 2025 | 10 | 0.230 |
Why?
| | Patient Discharge | 2 | 2019 | 325 | 0.230 |
Why?
| | Hospitals, Pediatric | 3 | 2015 | 243 | 0.230 |
Why?
| | Cells, Cultured | 5 | 2020 | 1569 | 0.230 |
Why?
| | Continuous Positive Airway Pressure | 2 | 2018 | 65 | 0.230 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2025 | 20 | 0.230 |
Why?
| | Telomere Homeostasis | 1 | 2025 | 11 | 0.220 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2025 | 17 | 0.220 |
Why?
| | Embryo, Mammalian | 1 | 2025 | 71 | 0.220 |
Why?
| | Telomere | 1 | 2025 | 38 | 0.220 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2004 | 12 | 0.220 |
Why?
| | Potassium | 1 | 2004 | 53 | 0.220 |
Why?
| | Infant Equipment | 1 | 2024 | 4 | 0.220 |
Why?
| | Ovum | 1 | 2024 | 7 | 0.220 |
Why?
| | Posture | 2 | 2024 | 65 | 0.210 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2025 | 148 | 0.210 |
Why?
| | Retrospective Studies | 9 | 2024 | 6819 | 0.210 |
Why?
| | DNA Copy Number Variations | 1 | 2024 | 117 | 0.200 |
Why?
| | Reactive Oxygen Species | 2 | 2022 | 421 | 0.200 |
Why?
| | Pyridines | 1 | 2004 | 135 | 0.200 |
Why?
| | Movement | 2 | 2021 | 80 | 0.200 |
Why?
| | Oximes | 2 | 2021 | 17 | 0.200 |
Why?
| | Sleep Apnea, Central | 1 | 2003 | 12 | 0.200 |
Why?
| | Polymerization | 1 | 2023 | 4 | 0.200 |
Why?
| | Respiratory Muscles | 1 | 2003 | 5 | 0.200 |
Why?
| | Parents | 3 | 2021 | 341 | 0.200 |
Why?
| | Respiratory System | 1 | 2003 | 28 | 0.190 |
Why?
| | Heart Rate | 1 | 2024 | 314 | 0.190 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2022 | 48 | 0.190 |
Why?
| | Neuronal Plasticity | 1 | 2003 | 44 | 0.190 |
Why?
| | Patient Selection | 1 | 2024 | 273 | 0.190 |
Why?
| | Feasibility Studies | 1 | 2024 | 411 | 0.190 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 2022 | 9 | 0.180 |
Why?
| | RNA, Messenger | 5 | 2020 | 1133 | 0.180 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2021 | 147 | 0.180 |
Why?
| | Cytoplasm | 1 | 2022 | 93 | 0.180 |
Why?
| | Ovary | 1 | 2022 | 103 | 0.180 |
Why?
| | Cardiology | 1 | 2023 | 106 | 0.180 |
Why?
| | Longevity | 1 | 2022 | 85 | 0.180 |
Why?
| | Heart Valve Prosthesis Implantation | 2 | 2021 | 103 | 0.180 |
Why?
| | Infertility, Female | 1 | 2021 | 18 | 0.180 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2015 | 1367 | 0.180 |
Why?
| | Intracellular Space | 2 | 2014 | 24 | 0.180 |
Why?
| | Methyltransferases | 1 | 2021 | 28 | 0.180 |
Why?
| | Catecholamines | 2 | 2013 | 44 | 0.180 |
Why?
| | Multicenter Studies as Topic | 4 | 2023 | 114 | 0.180 |
Why?
| | Decompression Sickness | 1 | 2021 | 1 | 0.170 |
Why?
| | In Vitro Oocyte Maturation Techniques | 1 | 2021 | 3 | 0.170 |
Why?
| | RNA, Small Interfering | 1 | 2021 | 214 | 0.170 |
Why?
| | Sepsis | 1 | 2024 | 240 | 0.170 |
Why?
| | Australia | 1 | 2021 | 93 | 0.170 |
Why?
| | Migraine Disorders | 1 | 2021 | 46 | 0.170 |
Why?
| | Thromboembolism | 1 | 2021 | 48 | 0.170 |
Why?
| | Histones | 1 | 2022 | 318 | 0.170 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 1925 | 0.170 |
Why?
| | Electrophysiology | 2 | 2011 | 60 | 0.160 |
Why?
| | Ventilators, Mechanical | 1 | 2020 | 43 | 0.160 |
Why?
| | Coenzyme A | 1 | 2019 | 9 | 0.160 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 133 | 0.150 |
Why?
| | Extracellular Matrix Proteins | 1 | 2020 | 69 | 0.150 |
Why?
| | Respiratory Mechanics | 2 | 2018 | 40 | 0.150 |
Why?
| | Action Potentials | 2 | 2013 | 116 | 0.150 |
Why?
| | Molecular Chaperones | 1 | 2020 | 76 | 0.150 |
Why?
| | Adolescent | 11 | 2018 | 6907 | 0.150 |
Why?
| | Obesity | 3 | 2022 | 1204 | 0.150 |
Why?
| | Tertiary Care Centers | 2 | 2018 | 86 | 0.150 |
Why?
| | Colorado | 1 | 2019 | 24 | 0.150 |
Why?
| | Nitric Oxide | 2 | 2011 | 233 | 0.150 |
Why?
| | Disease Management | 2 | 2021 | 187 | 0.150 |
Why?
| | Plethysmography | 1 | 2018 | 43 | 0.140 |
Why?
| | Disease Models, Animal | 4 | 2022 | 1517 | 0.140 |
Why?
| | Atrial Fibrillation | 2 | 2018 | 197 | 0.140 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 268 | 0.140 |
Why?
| | Ion Channel Gating | 2 | 2011 | 30 | 0.140 |
Why?
| | DNA Methylation | 1 | 2022 | 592 | 0.140 |
Why?
| | Child, Preschool | 8 | 2018 | 4162 | 0.140 |
Why?
| | Supine Position | 3 | 2024 | 26 | 0.140 |
Why?
| | Prone Position | 3 | 2024 | 29 | 0.140 |
Why?
| | Membrane Potential, Mitochondrial | 2 | 2015 | 44 | 0.140 |
Why?
| | Databases, Factual | 2 | 2019 | 742 | 0.140 |
Why?
| | Recovery of Function | 1 | 2019 | 203 | 0.140 |
Why?
| | Spirometry | 1 | 2018 | 33 | 0.140 |
Why?
| | Secondary Prevention | 1 | 2018 | 85 | 0.130 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 579 | 0.130 |
Why?
| | Hemodynamics | 1 | 2019 | 236 | 0.130 |
Why?
| | KCNQ2 Potassium Channel | 1 | 2017 | 8 | 0.130 |
Why?
| | Myoclonus | 1 | 2017 | 9 | 0.130 |
Why?
| | Phosphorylation | 2 | 2019 | 533 | 0.130 |
Why?
| | Spasms, Infantile | 1 | 2017 | 31 | 0.120 |
Why?
| | Prospective Studies | 5 | 2024 | 2411 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2017 | 505 | 0.120 |
Why?
| | bcl-2-Associated X Protein | 1 | 2016 | 58 | 0.120 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 21 | 0.120 |
Why?
| | Epitopes | 1 | 2016 | 61 | 0.120 |
Why?
| | Hospitals, Special | 1 | 2016 | 9 | 0.120 |
Why?
| | Molecular Typing | 1 | 2015 | 10 | 0.120 |
Why?
| | Length of Stay | 1 | 2019 | 684 | 0.120 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2015 | 28 | 0.120 |
Why?
| | Metaphase | 1 | 2015 | 47 | 0.120 |
Why?
| | Arteries | 2 | 2009 | 93 | 0.120 |
Why?
| | Manikins | 1 | 2015 | 33 | 0.120 |
Why?
| | Cell Cycle Proteins | 2 | 2022 | 170 | 0.120 |
Why?
| | Patient Care Team | 2 | 2015 | 278 | 0.120 |
Why?
| | Pseudomonas Infections | 1 | 2015 | 54 | 0.120 |
Why?
| | Alkynes | 1 | 2015 | 6 | 0.120 |
Why?
| | Pseudomonas aeruginosa | 1 | 2015 | 78 | 0.110 |
Why?
| | Intracellular Fluid | 1 | 2015 | 11 | 0.110 |
Why?
| | Sodium Compounds | 1 | 2015 | 10 | 0.110 |
Why?
| | Coinfection | 1 | 2015 | 41 | 0.110 |
Why?
| | DNA, Bacterial | 1 | 2015 | 167 | 0.110 |
Why?
| | Cardiac Surgical Procedures | 1 | 2018 | 331 | 0.110 |
Why?
| | Patient Safety | 1 | 2015 | 103 | 0.110 |
Why?
| | NAD | 1 | 2015 | 45 | 0.110 |
Why?
| | Boron Compounds | 1 | 2015 | 20 | 0.110 |
Why?
| | RNA | 2 | 2006 | 173 | 0.110 |
Why?
| | Sequence Alignment | 1 | 2015 | 119 | 0.110 |
Why?
| | Glycine | 1 | 2015 | 75 | 0.110 |
Why?
| | Mutation | 3 | 2022 | 1337 | 0.110 |
Why?
| | Computer Simulation | 1 | 2015 | 290 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2024 | 630 | 0.110 |
Why?
| | Embolism, Paradoxical | 1 | 2014 | 4 | 0.110 |
Why?
| | Polymerase Chain Reaction | 1 | 2015 | 452 | 0.110 |
Why?
| | Databases, Genetic | 1 | 2015 | 82 | 0.110 |
Why?
| | Tacrolimus | 1 | 2015 | 61 | 0.110 |
Why?
| | Foreign Bodies | 1 | 2015 | 66 | 0.110 |
Why?
| | Genotype | 1 | 2015 | 563 | 0.110 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2014 | 2 | 0.110 |
Why?
| | Ribonucleotides | 1 | 2014 | 4 | 0.110 |
Why?
| | Pyrones | 1 | 2014 | 8 | 0.110 |
Why?
| | Enzyme Activators | 1 | 2014 | 8 | 0.110 |
Why?
| | PC12 Cells | 1 | 2014 | 23 | 0.110 |
Why?
| | Reference Values | 3 | 2011 | 311 | 0.110 |
Why?
| | Oxidative Stress | 3 | 2024 | 819 | 0.100 |
Why?
| | Biphenyl Compounds | 1 | 2014 | 31 | 0.100 |
Why?
| | Sodium Cyanide | 1 | 2013 | 2 | 0.100 |
Why?
| | Forced Expiratory Volume | 1 | 2014 | 51 | 0.100 |
Why?
| | Thiophenes | 1 | 2014 | 45 | 0.100 |
Why?
| | Respiratory Distress Syndrome, Newborn | 2 | 2011 | 45 | 0.100 |
Why?
| | Postoperative Complications | 4 | 2026 | 1099 | 0.100 |
Why?
| | Quality of Health Care | 1 | 2015 | 189 | 0.100 |
Why?
| | Rural Population | 1 | 2018 | 596 | 0.100 |
Why?
| | Genomics | 1 | 2015 | 271 | 0.100 |
Why?
| | Follow-Up Studies | 6 | 2017 | 2318 | 0.100 |
Why?
| | Referral and Consultation | 1 | 2015 | 299 | 0.090 |
Why?
| | Software | 1 | 2015 | 280 | 0.090 |
Why?
| | Colostomy | 1 | 2012 | 11 | 0.090 |
Why?
| | Patient Advocacy | 1 | 2012 | 17 | 0.090 |
Why?
| | Pediatric Nursing | 1 | 2012 | 16 | 0.090 |
Why?
| | Prevalence | 1 | 2015 | 1034 | 0.090 |
Why?
| | Antibodies, Monoclonal | 1 | 2016 | 477 | 0.090 |
Why?
| | Administration, Intravenous | 1 | 2012 | 73 | 0.090 |
Why?
| | Receptors, Purinergic P2Y12 | 1 | 2012 | 17 | 0.090 |
Why?
| | Receptors, Purinergic P2 | 1 | 2012 | 26 | 0.090 |
Why?
| | Nocturnal Myoclonus Syndrome | 1 | 2011 | 13 | 0.090 |
Why?
| | Narcolepsy | 1 | 2011 | 12 | 0.090 |
Why?
| | Patient Compliance | 1 | 2013 | 232 | 0.090 |
Why?
| | Disabled Children | 1 | 2012 | 62 | 0.090 |
Why?
| | Severity of Illness Index | 4 | 2021 | 1049 | 0.090 |
Why?
| | Respiratory Physiological Phenomena | 2 | 2019 | 11 | 0.090 |
Why?
| | Telemedicine | 1 | 2018 | 512 | 0.090 |
Why?
| | Cyanides | 1 | 2011 | 4 | 0.090 |
Why?
| | Glyburide | 1 | 2011 | 5 | 0.090 |
Why?
| | Receptors, Drug | 1 | 2011 | 4 | 0.090 |
Why?
| | Biophysics | 1 | 2011 | 12 | 0.090 |
Why?
| | Diazoxide | 1 | 2011 | 7 | 0.090 |
Why?
| | KATP Channels | 1 | 2011 | 6 | 0.090 |
Why?
| | Sweetening Agents | 1 | 2011 | 14 | 0.090 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2011 | 35 | 0.090 |
Why?
| | Electric Stimulation | 1 | 2011 | 103 | 0.090 |
Why?
| | Collagen | 2 | 2022 | 215 | 0.080 |
Why?
| | Apoptosis | 1 | 2016 | 1139 | 0.080 |
Why?
| | Ataxia Telangiectasia | 1 | 2010 | 7 | 0.080 |
Why?
| | Bronchiectasis | 1 | 2010 | 8 | 0.080 |
Why?
| | Vasodilator Agents | 1 | 2011 | 90 | 0.080 |
Why?
| | Rubinstein-Taybi Syndrome | 1 | 2010 | 3 | 0.080 |
Why?
| | Electromyography | 2 | 2021 | 128 | 0.080 |
Why?
| | Lung Diseases, Interstitial | 1 | 2010 | 27 | 0.080 |
Why?
| | Ubiquitin-Protein Ligase Complexes | 1 | 2009 | 6 | 0.080 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2010 | 40 | 0.080 |
Why?
| | Blood Pressure | 3 | 2005 | 518 | 0.080 |
Why?
| | Carbon Dioxide | 1 | 2010 | 97 | 0.080 |
Why?
| | Deglutition Disorders | 2 | 2010 | 76 | 0.080 |
Why?
| | Arkansas | 1 | 2016 | 2068 | 0.080 |
Why?
| | Bronchodilator Agents | 1 | 2010 | 73 | 0.080 |
Why?
| | Recurrence | 2 | 2024 | 694 | 0.080 |
Why?
| | Glossopharyngeal Nerve | 1 | 2009 | 2 | 0.080 |
Why?
| | Potassium Chloride | 1 | 2009 | 17 | 0.080 |
Why?
| | Ruthenium Red | 1 | 2009 | 5 | 0.080 |
Why?
| | Gene Silencing | 1 | 2009 | 122 | 0.080 |
Why?
| | Isomerism | 1 | 2009 | 23 | 0.080 |
Why?
| | Potassium Channel Blockers | 1 | 2009 | 15 | 0.080 |
Why?
| | Arachidonic Acids | 1 | 2009 | 23 | 0.070 |
Why?
| | Magnesium | 1 | 2009 | 33 | 0.070 |
Why?
| | Coloring Agents | 1 | 2009 | 65 | 0.070 |
Why?
| | Hypoglycemic Agents | 1 | 2011 | 227 | 0.070 |
Why?
| | Glucose | 1 | 2011 | 361 | 0.070 |
Why?
| | Prognosis | 3 | 2021 | 2118 | 0.070 |
Why?
| | Crohn Disease | 1 | 2010 | 116 | 0.070 |
Why?
| | Lung | 2 | 2022 | 481 | 0.070 |
Why?
| | HeLa Cells | 1 | 2009 | 243 | 0.070 |
Why?
| | Carrier Proteins | 1 | 2009 | 315 | 0.070 |
Why?
| | Propensity Score | 2 | 2019 | 170 | 0.070 |
Why?
| | Fibrinolytic Agents | 2 | 2018 | 132 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2012 | 1003 | 0.060 |
Why?
| | Adult | 4 | 2018 | 14534 | 0.060 |
Why?
| | Incidence | 3 | 2015 | 1085 | 0.060 |
Why?
| | Diagnosis, Differential | 2 | 2015 | 1038 | 0.060 |
Why?
| | Algorithms | 2 | 2024 | 667 | 0.060 |
Why?
| | Hospitals, Low-Volume | 1 | 2026 | 17 | 0.060 |
Why?
| | Hospitals, High-Volume | 1 | 2026 | 26 | 0.060 |
Why?
| | Blastomeres | 1 | 2025 | 2 | 0.060 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 22 | 0.060 |
Why?
| | Rotenone | 1 | 2025 | 13 | 0.060 |
Why?
| | Quinpirole | 1 | 2005 | 2 | 0.060 |
Why?
| | Sulpiride | 1 | 2005 | 3 | 0.060 |
Why?
| | Ubiquinone | 1 | 2025 | 14 | 0.060 |
Why?
| | Mountaineering | 1 | 2005 | 2 | 0.060 |
Why?
| | Dopamine Agonists | 1 | 2005 | 10 | 0.060 |
Why?
| | Dopamine Antagonists | 1 | 2005 | 22 | 0.060 |
Why?
| | Medulla Oblongata | 2 | 1995 | 15 | 0.060 |
Why?
| | Acclimatization | 1 | 2005 | 24 | 0.060 |
Why?
| | Fetal Diseases | 1 | 2005 | 54 | 0.050 |
Why?
| | Isoenzymes | 1 | 2025 | 165 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2025 | 171 | 0.050 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2005 | 107 | 0.050 |
Why?
| | Survival Rate | 2 | 2017 | 949 | 0.050 |
Why?
| | Medical History Taking | 1 | 2004 | 47 | 0.050 |
Why?
| | Oxygen Consumption | 1 | 2005 | 201 | 0.050 |
Why?
| | Metformin | 1 | 2025 | 84 | 0.050 |
Why?
| | Circadian Rhythm | 1 | 2004 | 91 | 0.050 |
Why?
| | Hospital Mortality | 1 | 2026 | 457 | 0.050 |
Why?
| | Snoring | 1 | 2003 | 9 | 0.050 |
Why?
| | Gene Expression | 1 | 2006 | 618 | 0.050 |
Why?
| | DNA End-Joining Repair | 1 | 2023 | 18 | 0.050 |
Why?
| | Catheters | 1 | 2023 | 34 | 0.050 |
Why?
| | Etoposide | 1 | 2023 | 71 | 0.050 |
Why?
| | Mammals | 1 | 2023 | 58 | 0.050 |
Why?
| | Physical Examination | 1 | 2004 | 96 | 0.050 |
Why?
| | Genes, Developmental | 1 | 2022 | 1 | 0.050 |
Why?
| | Reflex | 1 | 2003 | 30 | 0.050 |
Why?
| | Receptors, Dopamine D1 | 1 | 2003 | 7 | 0.050 |
Why?
| | International Cooperation | 1 | 2003 | 52 | 0.050 |
Why?
| | Nervous System | 1 | 2003 | 32 | 0.050 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2024 | 150 | 0.050 |
Why?
| | X-Ray Microtomography | 1 | 2022 | 80 | 0.050 |
Why?
| | Hospitals | 1 | 2024 | 181 | 0.050 |
Why?
| | Gestational Age | 1 | 2024 | 394 | 0.050 |
Why?
| | Collagen Type V | 1 | 2022 | 4 | 0.050 |
Why?
| | Haploinsufficiency | 1 | 2022 | 15 | 0.050 |
Why?
| | Respiratory Function Tests | 2 | 2014 | 89 | 0.050 |
Why?
| | DNA Repair | 1 | 2023 | 197 | 0.050 |
Why?
| | Fetus | 1 | 2003 | 191 | 0.040 |
Why?
| | Pharynx | 2 | 2015 | 31 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 198 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2021 | 1219 | 0.040 |
Why?
| | Health Care Surveys | 1 | 2021 | 182 | 0.040 |
Why?
| | Administration, Inhalation | 2 | 2011 | 108 | 0.040 |
Why?
| | Ventilator Weaning | 1 | 2020 | 21 | 0.040 |
Why?
| | Syndrome | 1 | 2021 | 248 | 0.040 |
Why?
| | Consensus | 1 | 2021 | 206 | 0.040 |
Why?
| | Hep G2 Cells | 1 | 2019 | 38 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2019 | 155 | 0.040 |
Why?
| | Protein Conformation | 1 | 2019 | 174 | 0.040 |
Why?
| | Protein Processing, Post-Translational | 1 | 2020 | 149 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2019 | 235 | 0.040 |
Why?
| | Transcriptome | 1 | 2021 | 367 | 0.040 |
Why?
| | Muscle, Skeletal | 1 | 2024 | 815 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2020 | 243 | 0.040 |
Why?
| | Clinical Protocols | 1 | 2019 | 109 | 0.040 |
Why?
| | Models, Econometric | 1 | 2018 | 13 | 0.040 |
Why?
| | Monitoring, Physiologic | 1 | 2019 | 122 | 0.040 |
Why?
| | Models, Molecular | 1 | 2019 | 352 | 0.030 |
Why?
| | Markov Chains | 1 | 2018 | 28 | 0.030 |
Why?
| | Heart Valve Prosthesis | 1 | 2019 | 89 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2019 | 445 | 0.030 |
Why?
| | Cause of Death | 1 | 2018 | 156 | 0.030 |
Why?
| | Health Resources | 1 | 2018 | 72 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2018 | 266 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2011 | 198 | 0.030 |
Why?
| | Community Health Services | 1 | 2018 | 102 | 0.030 |
Why?
| | Histidine | 1 | 2017 | 15 | 0.030 |
Why?
| | Quality Assurance, Health Care | 1 | 2018 | 146 | 0.030 |
Why?
| | Hemorrhage | 1 | 2018 | 226 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2018 | 274 | 0.030 |
Why?
| | Cysteine | 1 | 2017 | 50 | 0.030 |
Why?
| | Models, Statistical | 1 | 2018 | 229 | 0.030 |
Why?
| | Research Design | 1 | 2019 | 373 | 0.030 |
Why?
| | Epitope Mapping | 1 | 2016 | 6 | 0.030 |
Why?
| | Cytochromes c | 1 | 2016 | 28 | 0.030 |
Why?
| | Societies | 1 | 2016 | 8 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2016 | 50 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2016 | 97 | 0.030 |
Why?
| | Cytosol | 1 | 2016 | 80 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 726 | 0.030 |
Why?
| | Molecular Dynamics Simulation | 1 | 2016 | 44 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2016 | 57 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2016 | 93 | 0.030 |
Why?
| | Middle Aged | 2 | 2024 | 13419 | 0.030 |
Why?
| | Quality Improvement | 1 | 2018 | 230 | 0.030 |
Why?
| | Anticoagulants | 1 | 2018 | 280 | 0.030 |
Why?
| | Anticonvulsants | 1 | 2017 | 133 | 0.030 |
Why?
| | Arginine | 1 | 2017 | 178 | 0.030 |
Why?
| | Palate | 1 | 2015 | 12 | 0.030 |
Why?
| | Uvula | 1 | 2015 | 13 | 0.030 |
Why?
| | Cinnamates | 1 | 2015 | 2 | 0.030 |
Why?
| | Thiourea | 1 | 2015 | 7 | 0.030 |
Why?
| | Bronchography | 1 | 2015 | 6 | 0.030 |
Why?
| | Young Adult | 2 | 2018 | 4511 | 0.030 |
Why?
| | Computing Methodologies | 1 | 2015 | 2 | 0.030 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2015 | 19 | 0.030 |
Why?
| | Genetic Techniques | 1 | 2015 | 15 | 0.030 |
Why?
| | Electroencephalography | 1 | 2017 | 305 | 0.030 |
Why?
| | Adenoidectomy | 1 | 2015 | 36 | 0.030 |
Why?
| | Heart Failure | 2 | 2015 | 531 | 0.030 |
Why?
| | Bronchi | 1 | 2015 | 42 | 0.030 |
Why?
| | Afferent Pathways | 1 | 1994 | 10 | 0.030 |
Why?
| | Hypoxia, Brain | 1 | 1994 | 13 | 0.030 |
Why?
| | Tonsillectomy | 1 | 2015 | 50 | 0.030 |
Why?
| | Respiratory Sounds | 1 | 2015 | 51 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 51 | 0.030 |
Why?
| | Cough | 1 | 2015 | 58 | 0.030 |
Why?
| | Heart Valve Diseases | 1 | 2015 | 55 | 0.030 |
Why?
| | Swine | 1 | 2016 | 440 | 0.030 |
Why?
| | Balloon Occlusion | 1 | 2014 | 17 | 0.030 |
Why?
| | Protein Binding | 1 | 2016 | 670 | 0.030 |
Why?
| | Bronchoscopy | 1 | 2015 | 78 | 0.030 |
Why?
| | Fibroblasts | 1 | 2016 | 363 | 0.030 |
Why?
| | Cardiovascular Agents | 1 | 2014 | 66 | 0.030 |
Why?
| | Phenotype | 1 | 2017 | 803 | 0.030 |
Why?
| | Caregivers | 1 | 2016 | 247 | 0.030 |
Why?
| | Staff Development | 1 | 2013 | 26 | 0.020 |
Why?
| | Seizures | 1 | 2015 | 203 | 0.020 |
Why?
| | Professional-Patient Relations | 1 | 2013 | 46 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2016 | 681 | 0.020 |
Why?
| | Professional Role | 1 | 2013 | 85 | 0.020 |
Why?
| | Ambulatory Care Facilities | 1 | 2013 | 121 | 0.020 |
Why?
| | Internet | 1 | 2015 | 265 | 0.020 |
Why?
| | Patient Readmission | 1 | 2015 | 251 | 0.020 |
Why?
| | Social Isolation | 1 | 2012 | 29 | 0.020 |
Why?
| | Professional-Family Relations | 1 | 2012 | 43 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2015 | 975 | 0.020 |
Why?
| | Quality of Life | 1 | 2018 | 902 | 0.020 |
Why?
| | Sleep, REM | 1 | 2011 | 43 | 0.020 |
Why?
| | Sex Distribution | 1 | 2011 | 140 | 0.020 |
Why?
| | Age Distribution | 1 | 2011 | 175 | 0.020 |
Why?
| | Ambulatory Care | 1 | 2013 | 239 | 0.020 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2011 | 6 | 0.020 |
Why?
| | Potassium Channels | 1 | 2011 | 32 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2011 | 52 | 0.020 |
Why?
| | Emotions | 1 | 2012 | 177 | 0.020 |
Why?
| | Schools | 1 | 2012 | 185 | 0.020 |
Why?
| | Social Support | 1 | 2012 | 272 | 0.020 |
Why?
| | Patient Education as Topic | 1 | 2013 | 325 | 0.020 |
Why?
| | Stress, Psychological | 1 | 2012 | 282 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 1583 | 0.020 |
Why?
| | Comorbidity | 1 | 2011 | 638 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 1180 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 275 | 0.020 |
Why?
| | Gene Deletion | 1 | 2010 | 279 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2011 | 1212 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2010 | 466 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2010 | 502 | 0.020 |
Why?
| | Barium Sulfate | 1 | 2006 | 12 | 0.020 |
Why?
| | Respiratory Aspiration | 1 | 2006 | 8 | 0.020 |
Why?
| | Fluoroscopy | 1 | 2006 | 49 | 0.020 |
Why?
| | Video Recording | 1 | 2006 | 81 | 0.020 |
Why?
| | Contrast Media | 1 | 2006 | 178 | 0.010 |
Why?
| | Cardiac Volume | 1 | 2005 | 6 | 0.010 |
Why?
| | Diastole | 1 | 2005 | 66 | 0.010 |
Why?
| | Carotid Sinus | 2 | 1995 | 5 | 0.010 |
Why?
| | Denervation | 2 | 1995 | 19 | 0.010 |
Why?
| | Systole | 1 | 2005 | 71 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2005 | 99 | 0.010 |
Why?
| | Cats | 2 | 1995 | 75 | 0.010 |
Why?
| | Myocardial Contraction | 1 | 2005 | 109 | 0.010 |
Why?
| | Oxyhemoglobins | 1 | 2004 | 4 | 0.010 |
Why?
| | Blood Gas Analysis | 1 | 2004 | 28 | 0.010 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2004 | 34 | 0.010 |
Why?
| | Arousal | 1 | 2004 | 104 | 0.010 |
Why?
| | Ventricular Function, Left | 1 | 2005 | 178 | 0.010 |
Why?
| | Ganglia, Sensory | 1 | 2003 | 1 | 0.010 |
Why?
| | Superior Cervical Ganglion | 1 | 2003 | 5 | 0.010 |
Why?
| | Corpus Striatum | 1 | 2003 | 47 | 0.010 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2003 | 77 | 0.010 |
Why?
| | International Classification of Diseases | 1 | 2003 | 70 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2003 | 370 | 0.010 |
Why?
| | Rabbits | 1 | 2003 | 372 | 0.010 |
Why?
| | Echocardiography | 1 | 2005 | 409 | 0.010 |
Why?
| | Body Mass Index | 1 | 2004 | 717 | 0.010 |
Why?
| | Vagotomy | 1 | 1995 | 4 | 0.010 |
Why?
| | Nitroprusside | 1 | 1995 | 10 | 0.010 |
Why?
| | Optics and Photonics | 1 | 1995 | 8 | 0.010 |
Why?
| | Phenylephrine | 1 | 1995 | 36 | 0.010 |
Why?
| | Light | 1 | 1995 | 51 | 0.010 |
Why?
| | Tidal Volume | 1 | 1994 | 61 | 0.010 |
Why?
| | Cerebral Cortex | 1 | 1995 | 194 | 0.010 |
Why?
| | Electrocardiography | 1 | 1994 | 273 | 0.010 |
Why?
|
|
Carroll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|